Immunohistochemical studies on lung adenocarcinoma tissue microarray demonstrated that patients with high PCK1 expression had a worse prognosis, compatible to the findings in literature (Fig. 6F, G). The gene discussed is PCK1; the disease is lung adenocarcinoma.